Maggi noodles Nestle row
Food regulator allots Rs.500 crore for lab upgradation, seeks private partners. In Picture: A vendor with a packet of Maggi noodles at a grocery shop in Kolkata, India, June 3, 2015. [Representational Image]Reuters

Maggi noodles may soon return to shelves, as the tests conducted at labs mandated by the Bombay High Court show that the instant food is safe for consumption.

Nestle India, the manufacturer of the banned Maggi noodle, said that it has obtained the sample test results from the three laboratories designated by the court to test the safety levels of noodles.

"All 90 samples, covering 6 variants, tested by these laboratories are clear with lead much below permissible limits," said Nestle India in a press statement to the Bombay Stock Exchange (BSE).

Following the announcement, Nestle India shares soared over 6% to Rs 6,599 on the BSE.

The company said that it has carried out more than 3,500 tests on 200 million packs of Maggi noodles at recognised labs located in India and abroad.

"All the reports are clear," quoted Nestle India as saying.

Nevertheless, the company said that it would resume selling Maggi noodles "only after the newly manufactured products are also cleared by the designated three laboratories."

On 5 June, the Food Safety & Standards Authority of India (FSSAI), the country's food regulator, had ordered Nestle India to recall all available stocks of Maggi noodles after finding harmful levels of lead and monosodium glutamate (MSG) in tested samples.

Nestle India challenged the ban in the Bombay High Court, which subsequently overruled the FSSAI order. However, the court said that Nestle India can resume the sale of Maggi noodles only after the samples are tested safe for consumption by the government-approved laboratories.

Also read